FDA Approved: REMODULIN — Supplemental Application (United Therapeutics Corporation)

View source ↗

Summary

The U.S. FDA approved a supplemental application for REMODULIN (treprostinil) filed by United Therapeutics Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Remodulin (treprostinil)

Snippet

SUPPL AP for REMODULIN (TREPROSTINIL)